Camp4 Therapeutics (CAMP) Return on Capital Employed (2024 - 2026)
Camp4 Therapeutics recorded quarterly Return on Capital Employed of 55.29% in Q1 2026, up 8.91% quarter-over-quarter from 60.7% in Q4 2025, and up 2789.0% year-over-year from 1.91% in Q1 2025.
Camp4 Therapeutics' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 55.29% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 2789.0% year-over-year to 55.29%; the TTM figure through Mar 2026 stood at 55.29% (up 2789.0% YoY), while the FY2025 annual figure was 63.67%, up 2942.0% from the prior year.
- Return on Capital Employed came in at 55.29% for Q1 2026 at Camp4 Therapeutics, up from 60.7% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 55.29% in Q1 2026 to a low of 131.93% in Q4 2024.
- A 3-year average of 87.91% and a median of 85.74% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 7124 bps in 2025 and jumped 2789 bps in 2026, its largest moves.
- Camp4 Therapeutics' Return on Capital Employed stood at 131.93% in 2024, then surged by 54 bps to 60.7% in 2025, then increased by 9 bps to 55.29% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 55.29%, 60.7%, and 88.32% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -55.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.29% |
| Dec 31, 2025 | -60.70% |
| Sep 30, 2025 | -88.32% |
| Jun 30, 2025 | -108.03% |
| Mar 31, 2025 | -83.17% |
| Dec 31, 2024 | -131.93% |